Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CNTX will rise by +0.49% over the next 2 Weeks and hit $3.14 by Friday, March 20, 2026. In that time frame, CNTX's share price is expected to range between $2.98 and $3.29.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 20, 2026 | 2.98 | 3.14 | 3.29 |
| Mar 19, 2026 | 3.02 | 3.18 | 3.34 |
| Mar 18, 2026 | 3.05 | 3.21 | 3.36 |
| Mar 17, 2026 | 3.04 | 3.19 | 3.35 |
| Mar 16, 2026 | 2.97 | 3.11 | 3.24 |
| Mar 13, 2026 | 2.98 | 3.13 | 3.26 |
| Mar 12, 2026 | 3.03 | 3.17 | 3.30 |
| Mar 11, 2026 | 3.05 | 3.20 | 3.34 |
| Mar 10, 2026 | 3.05 | 3.19 | 3.32 |
| Mar 9, 2026 | 2.97 | 3.10 | 3.24 |
CNTX shares rose +9.09% in Friday, March 6, 2026's trading session, rising from a previous close of $2.86 to move at $3.12. The stock demonstrated notable intraday movement (see CNTX's key stats for a full breakdown), fluctuating between $2.74 and $3.30, a +20.26% trading range. While recent weeks have seen some volatility, CNTX has managed to secure a +34.48% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.42M shares changing hands, 1.6M more than the previous session. This amounted to $7.54M in total market activity.
Will CNTX Continue Its Upward Trend?
According to analyst ratings and projections for CNTX, Context Therapeutics Inc. shares are anticipated to increase by +5.11%, potentially reaching $3.29 per share by March 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for CNTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the CNTX stock forecast, now is a good time to buy CNTX stock because its current trading price is -0.49% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CNTX covering social and institutional perspectives.
CNTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CNTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 73.07% to 81.26%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 67.92%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 63.54%, points to growing bullish momentum over the long term. Insights into CNTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Context Therapeutics Short-Term Forecasts
CNTX Forecast For Next 5 Days
Our algorithm anticipates Context Therapeutics (CNTX) stock could hit $2.52 by Mar 13, 2026. This represents a -19.20% rise from today's price, following a +3.36% change over the past five days.
CNTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Context Therapeutics Inc. (CNTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.48, which would mean a -20.51% decrease from the current price of $3.12. Projections for this period range from a high of $3.08 to a low of $1.90.
CNTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Context Therapeutics's price over the next three months point to a rise. CNTX stock is expected to peak at $34.06 on Jun 05, 2026 after potentially dipping to $22.68 on Mar 09, 2026. On average, CNTX is likely to trade around $28.25 in the coming 90 days.
Context Therapeutics Stock Forecast 2025
Based on our predictive models, Context Therapeutics (CNTX) is expected to trade between $22.68 and $40.78 throughout 2026. This would result in an average price of $32.30, potentially offering investors a +935.26% return from current levels.
Context Therapeutics Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Context Therapeutics Inc. (CNTX) is positioned to show a strong performance in March 2026. The price is predicted to move between $22.68 and $23.71, settling at an average of $23.11. This could translate to a +640.71% gain.
April 2026
Based on current market signals, Context Therapeutics Inc. is projected to trend april 2026. We forecast a trading range from $23.81 to $30.66, with a likely average price of $27.45. Investors could expect a potential return of +779.81%.
May 2026
Our predictive algorithms indicate Context Therapeutics Inc. stock may see a shift in May 2026. The expected range spans $30.44–$33.65, with an average target of $32.08. This represents a positive outlook and a possible gain of +928.21%.
June 2026
Analyzing established trends, Context Therapeutics Inc. looks set to move in June 2026. Projections place the stock between $32.95 and $40.65, averaging around $35.70. This suggests a +1,044.23% gain from current levels.
July 2026
Market indicators suggest Context Therapeutics Inc. could experience notable changes during July 2026. Prices could fluctuate within $35.44 to $40.78, with a midpoint forecast of $36.80. The stock might deliver a +1,079.49% gain.
August 2026
Forecasting for August 2026, models estimate that Context Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $35.47 and $39.61, averaging $36.07. This signals a positive trajectory with potential returns around +1,056.09%.
September 2026
According to our latest forecast models, Context Therapeutics Inc. (CNTX) is positioned to show a strong performance in September 2026. The price is predicted to move between $34.25 and $37.35, settling at an average of $34.00. This could translate to a +989.74% gain.
October 2026
Based on current market signals, Context Therapeutics Inc. is projected to trend october 2026. We forecast a trading range from $34.26 to $38.82, with a likely average price of $33.93. Investors could expect a potential return of +987.50%.
November 2026
Our predictive algorithms indicate Context Therapeutics Inc. stock may see a shift in November 2026. The expected range spans $32.96–$37.35, with an average target of $32.29. This represents a positive outlook and a possible gain of +934.94%.
December 2026
Analyzing established trends, Context Therapeutics Inc. looks set to move in December 2026. Projections place the stock between $30.39 and $34.75, averaging around $29.54. This suggests a +846.79% gain from current levels.
January 2027
Market indicators suggest Context Therapeutics Inc. could experience notable changes during January 2027. Prices could fluctuate within $32.91 to $38.03, with a midpoint forecast of $31.45. The stock might deliver a +908.01% gain.
February 2027
Forecasting for February 2027, models estimate that Context Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $37.16 and $43.80, averaging $36.65. This signals a positive trajectory with potential returns around +1,074.68%.
March 2027
According to our latest forecast models, Context Therapeutics Inc. (CNTX) is positioned to show a strong performance in March 2027. The price is predicted to move between $37.65 and $39.90, settling at an average of $34.48. This could translate to a +1,005.13% gain.
CNTX's history of dividends and stock splits also plays a role in long-term investor confidence.